Search - tctmd.com

Displaying 161 - 180 of 411

Sort: Relevancy | Date

Presentation TCT 2019

Strokes After TAVR Are Rare and Cerebral Protection Is Unnecessary

Presenter: David Hildick-Smith

September 26, 2019

News Conference News TCT 2019

Strokes Increasing in STEMI Patients With Cardiogenic Shock

Todd Neale

September 25, 2019

Aortic Valve Intervention and Ancillary Solutions I: Featured Technological Trends - A Novel Left Transradial Cerebral Protection System for TAVR (The ProtEmbo System)

Presentation TCT 2019

A Novel Left Transradial Cerebral Protection System for TAVR (The ProtEmbo System)

Presenter: Tobias Schmidt

September 25, 2019

Aortic Valve Intervention and Ancillary Solutions I: Featured Technological Trends - Full Arch Cerebral Embolic Protection of the Brain (Point-Guard™) During Cardiovascular Procedures

Presentation TCT 2019

Full Arch Cerebral Embolic Protection of the Brain (Point-Guard™) During Cardiovascular Procedures

Presenter: Axel Linke

September 25, 2019

Presentation TCT 2019

TCT 23: Heterogeneity of Debris Captured by Cerebral Embolic Protection Filters During Transcatheter Aortic Valve Replacement With Different Transcatheter Heart Valves

Presenter: Nicolas van Mieghem

September 25, 2019

Presentation TCT 2019

State of Cerebral Protection in Patients Undergoing TAVR

Presenter: Axel Linke

September 25, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2019

Shelley Wood

June 28, 2019

News Conference News TVT 2019

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

Shelley Wood

June 13, 2019

Presentation TVT 2019

Rationalizing the Cost Effectiveness of Cerebral Protection During TAVR

Presenter: Hemal Gada

June 13, 2019

Presentation TVT 2019

Selective Use — Is There a Middle Ground?

Presenter: Jeffrey Moses

June 13, 2019

Presentation TVT 2019

Not Necessary — Soft Data and Excessive Costs!

Presenter: David Muller

June 13, 2019

Presentation TVT 2019

Systematic — In All Patients, Whenever Possible!

Presenter: Nicolas Van Mieghem

June 13, 2019

Presentation TVT 2019

Cerebral Embolic Protection for TAVR With TriGuard 3: Updates From the REFLECT Clinical Trial

Presenter: Tamim Nazif

June 13, 2019

Presentation TVT 2019

Comprehensive Review of the Sentinel Cerebral Embolic Protection Program

Presenter: Julia Seeger

June 13, 2019

Presentation TVT 2019

Status Updates on the Next Generation of Cerebral Protection Devices

Presenter: Giora Weisz

June 13, 2019

News Daily News

Similar Mortality, Higher Early Stroke Risks in TAVR for Bicuspid Aortic Stenosis

Michael O'Riordan

June 11, 2019

News Conference News EuroPCR 2019

Valve Leaflet Scoring Device for Aortic Stenosis Clears Feasibility Hurdle

Michael O'Riordan

May 23, 2019

News Daily News

FDA Approves Lotus Edge, Ushering Third Device Into US Market

Shelley Wood

April 24, 2019

News Industry News

Boston Scientific Receives FDA Approval for LOTUS Edge™ Aortic Valve System

April 23, 2019

Presentation SIF 2019

Debate Cerebral Embolic Protection: The Data are Compelling and the Costs Manageable

Presenter: Saif Anwaruddin

March 30, 2019

Advertisement

Strokes After TAVR Are Rare and Cerebral Protection Is Unnecessary

Strokes Increasing in STEMI Patients With Cardiogenic Shock

A Novel Left Transradial Cerebral Protection System for TAVR (The ProtEmbo System)

Full Arch Cerebral Embolic Protection of the Brain (Point-Guard™) During Cardiovascular Procedures

TCT 23: Heterogeneity of Debris Captured by Cerebral Embolic Protection Filters During Transcatheter Aortic Valve Replacement With Different Transcatheter Heart Valves

State of Cerebral Protection in Patients Undergoing TAVR

TCTMD’s Top 10 Most Popular Stories for June 2019

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

Rationalizing the Cost Effectiveness of Cerebral Protection During TAVR

Selective Use — Is There a Middle Ground?

Not Necessary — Soft Data and Excessive Costs!

Systematic — In All Patients, Whenever Possible!

Cerebral Embolic Protection for TAVR With TriGuard 3: Updates From the REFLECT Clinical Trial

Comprehensive Review of the Sentinel Cerebral Embolic Protection Program

Status Updates on the Next Generation of Cerebral Protection Devices

Similar Mortality, Higher Early Stroke Risks in TAVR for Bicuspid Aortic Stenosis

Valve Leaflet Scoring Device for Aortic Stenosis Clears Feasibility Hurdle

FDA Approves Lotus Edge, Ushering Third Device Into US Market

Boston Scientific Receives FDA Approval for LOTUS Edge™ Aortic Valve System

Debate Cerebral Embolic Protection: The Data are Compelling and the Costs Manageable

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content